← FDA DRUG APPROVALS

FDA ANDA · ANDA062773

CEPHALEXIN

Sponsor: BARR

APPLICATION
ANDA062773
TYPE
ANDA
ORIGINAL APPROVAL
1987-06-26
LATEST ACTION
1999-12-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CEPHALEXINDiscontinued
CEPHALEXIN EQ 250MG BASE · CAPSULE · ORAL

Approval history

1999-12-21Manufacturing (CMC) · Supplement 17AP
1999-05-20Manufacturing (CMC) · Supplement 16AP
1998-12-01Manufacturing (CMC) · Supplement 15AP
1997-04-01Labeling · Supplement 14AP
1997-02-13Manufacturing (CMC) · Supplement 13AP
1995-01-11Manufacturing (CMC) · Supplement 5AP
1994-12-23Manufacturing (CMC) · Supplement 12AP
1994-05-24Labeling · Supplement 11AP
1993-10-15Labeling · Supplement 10AP
1992-04-03Manufacturing (CMC) · Supplement 9AP
1992-04-03Manufacturing (CMC) · Supplement 7AP
1989-03-08Manufacturing (CMC) · Supplement 4AP
1987-06-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →